Home » Breakthrough Study: ACTU Project Launches Initiative to Explore Treatments for Persistent COVID

Breakthrough Study: ACTU Project Launches Initiative to Explore Treatments for Persistent COVID

by admin
Breakthrough Study: ACTU Project Launches Initiative to Explore Treatments for Persistent COVID

The ‘ACTU Project’ launches a pioneering initiative to explore treatments against persistent COVID

By: Maria Camila Sanchez
April 30, 2024

The School of Medicine of the Medical Sciences Campus of the University of Puerto Rico (UPR) has announced its collaboration with RECOVER-VITAL, a pioneering initiative aimed at exploring treatments against persistent COVID, also known as Long COVID or PASC (Post Acute Sequelae of SARS CoV-2 infection).

Led by the distinguished Dr. Jorge Santana Bagur, the ACTU Project is recruiting volunteers to participate in this highly important study. The objective is to investigate whether PAXLOVID, an antiviral medication that combines nirmatrelvir and ritonavir and has been used successfully in the treatment of mild to moderate infections of COVID-19, may be effective in treating prolonged COVID symptoms.

“The prolonged COVID is a condition that continues to affect the quality of life of many, and we still have much to learn about its management and treatment,” explained Dr. Santana Bagur. “This study is a crucial step in our search for answers and best practices to support patients in the long term.”

Part of a broader effort
RECOVER-VITAL is part of a broader effort called RECOVER, funded by the National Institutes of Health. This clinical trial is coordinated by the prestigious Duke Clinical Research Institute (DCRI) and has the collaboration of doctors Kanecia Zimmerman, Richard Whitley, and Lindsey Baden.

Participation and monitoring
Participants will take the study intervention for up to 25 days, with detailed follow-up to evaluate the effectiveness of the treatment. PAXLOVID is provided by Pfizer, Inc. and this study will help understand whether a course of prolonged treatment can offer sustained relief to patients.

See also  “No cancer is more preventable than colon cancer” – what you need to pay attention to

For more information and participation
For more information or to participate in the study, interested parties should contact the ACTU Project at 787-767-9192 or mobile 787-685-5290. You can also visit trials.recovercovid.org/vital for additional details about the study.

Commitment to public health
The School of Medicine of the UPR Medical Sciences Campus is committed to cutting-edge medical research and the well-being of the Puerto Rican community. This study is another example of their dedication to improving public health and contributing to global medical knowledge.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy